Literature DB >> 12865883

Epidemiology of venous insufficiency in an occupational population.

P Lacroix1, V Aboyans, P M Preux, M B Houlès, M Laskar.   

Abstract

AIM: A cross sectional study of the prevalence and risk factors of chronic venous insufficiency (CVI) in a South European occupational population was performed.
METHODS: Over a 7-month period a questionnaire (CVI symptoms, general data and life style habits) was administrated to 1604 consecutive females (73.3%) and 586 consecutive males (26.7%). An oriented clinical examination was then performed. Subjects were classified into 4 groups: asymptomatic, light, moderate and severe CVI. Univariate and multivariate analysis were used.
RESULTS: Mean age 38.8+/-11.6 years (range 15-65). The prevalence of CVI all classes confounded was 51.4% (62.3% in women and 21.8% in men); the prevalence of moderate and severe CVI was 10.4% (12.1% in female and 6.3% in male). Age (Odds Ratio (OR): 1.93, 95% confidence interval (CI): 1.55-3.53), female sex (OR: 2.34, 95% CI: 1.62-2.30), obesity (kg/m(2)) (OR:1.11, 95% CI: 1.07-1.15) and familial history of CVI (OR: 2.80, 95% CI: 2.02-3.89) were risks factors of moderate and severe CVI. The comparison extended to the whole group of CVI added other risk factors: history of leg injury, pregnancy; a sitting posture at work. Unexpectedly smoking had a protective effect but only in the female group for the last one.
CONCLUSION: CVI is an important medical problem concern in this population. Some of the risk factors like obesity and standing position at work may benefit from preventive measures.

Entities:  

Mesh:

Year:  2003        PMID: 12865883

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  11 in total

Review 1.  Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.

Authors:  Elisabeth MacColl; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2015-08-28       Impact factor: 4.030

Review 2.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 3.  Review of epidemiologic studies on occupational factors and lower extremity musculoskeletal and vascular disorders and symptoms.

Authors:  Jennifer C D'Souza; Alfred Franzblau; Robert A Werner
Journal:  J Occup Rehabil       Date:  2005-06

Review 4.  Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.

Authors:  Yunfei Chen; Wei Peng; Joseph D Raffetto; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-03-21       Impact factor: 3.622

5.  Distal lower-extremity pain and work postures in the Quebec population.

Authors:  Karen Messing; France Tissot; Susan Stock
Journal:  Am J Public Health       Date:  2007-08-29       Impact factor: 9.308

6.  Risk Factor, Job Stress and Quality of Life in Workers With Lower Extremity Pain Who Use Video Display Terminals.

Authors:  Sehoon Choi; Seong Ho Jang; Kyu Hoon Lee; Mi Jung Kim; Si-Bog Park; Seung Hoon Han
Journal:  Ann Rehabil Med       Date:  2018-02-28

Review 7.  Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy.

Authors:  Armando Mansilha; Joel Sousa
Journal:  Int J Mol Sci       Date:  2018-06-05       Impact factor: 5.923

8.  Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Vessel Plus       Date:  2021-05-29

9.  Varicose veins in hairdressers and associated risk factors: a cross-sectional study.

Authors:  Chao-Lin Chen; How-Ran Guo
Journal:  BMC Public Health       Date:  2014-08-28       Impact factor: 3.295

10.  Iliac venous stenting for outflow obstruction does not significantly change the quality of life of patients with severe chronic venous insufficiency.

Authors:  Alexander Shiferson; Edouard Aboian; Michael Shih; Qinghua Pu; Theresa Jacob; Robert Y Rhee
Journal:  JRSM Cardiovasc Dis       Date:  2019-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.